Mesoblast Historical Cash Flow
| MESO Stock | USD 18.69 0.13 0.69% |
Analysis of Mesoblast cash flow over time is an excellent tool to project Mesoblast future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 283 K or Total Cash From Financing Activities of 61.1 M as it is a great indicator of Mesoblast ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Mesoblast latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mesoblast is a good buy for the upcoming year.
Mesoblast |
About Mesoblast Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Mesoblast balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Mesoblast's non-liquid assets can be easily converted into cash.
Mesoblast Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Depreciation
Depreciation indicates how much of Mesoblast value has been used up. For tax purposes Mesoblast can deduct the cost of the tangible assets it purchases as business expenses. However, Mesoblast must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Mesoblast to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Mesoblast operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Mesoblast's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Mesoblast current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.At this time, Mesoblast's Sale Purchase Of Stock is very stable compared to the past year. As of the 7th of February 2025, Change To Operating Activities is likely to grow to about 521.6 K, though Change In Cash is likely to grow to (7.1 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Begin Period Cash Flow | 60.4M | 71.3M | 82.0M | 104.3M | End Period Cash Flow | 71.3M | 63.0M | 72.4M | 104.5M |
Mesoblast cash flow statement Correlations
Click cells to compare fundamentals
Mesoblast Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesoblast cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.6M | (76.4M) | 10.9M | (8.4M) | (7.5M) | (7.1M) | |
| Stock Based Compensation | 12.5M | 5.5M | 3.7M | 5.9M | 6.8M | 5.8M | |
| Free Cash Flow | (108.3M) | (66.0M) | (63.6M) | (48.8M) | (43.9M) | (46.1M) | |
| Change In Working Capital | (8.4M) | 4.9M | (2.5M) | (2.6M) | (2.4M) | (2.2M) | |
| Other Cashflows From Financing Activities | 5.2M | (3.8M) | (11.5M) | (11.6M) | (13.4M) | (12.7M) | |
| Depreciation | 4.3M | 4.4M | 4.1M | 4.7M | 5.4M | 5.6M | |
| Other Non Cash Items | (15.4M) | 11.0M | 13.5M | 31.8M | 36.6M | 38.4M | |
| Capital Expenditures | 1.6M | 232K | 314K | 331K | 297.9K | 283.0K | |
| Total Cash From Operating Activities | (106.7M) | (65.8M) | (63.3M) | (48.5M) | (43.6M) | (45.8M) | |
| Net Income | (98.8M) | (91.3M) | (81.9M) | (88.0M) | (79.2M) | (75.2M) | |
| Total Cash From Financing Activities | 114.5M | (9.9M) | 74.5M | 40.3M | 46.3M | 61.1M | |
| End Period Cash Flow | 136.9M | 60.4M | 71.3M | 63.0M | 72.4M | 104.5M | |
| Begin Period Cash Flow | 129.3M | 136.9M | 60.4M | 71.3M | 82.0M | 104.3M | |
| Change To Inventory | (12.5M) | 5.1M | (4.8M) | 398K | 358.2K | 376.1K | |
| Change To Account Receivables | (1.7M) | 140K | (118K) | (15.5M) | (13.9M) | (13.2M) | |
| Investments | (1.6M) | (232K) | (194K) | (97K) | (111.6K) | (117.1K) | |
| Total Cashflows From Investing Activities | (3.3M) | (1.6M) | (232K) | (194K) | (223.1K) | (234.3K) | |
| Change To Operating Activities | (1.6M) | (1.6M) | (48K) | 432K | 496.8K | 521.6K | |
| Other Cashflows From Investing Activities | 120K | (1.6M) | (75K) | (60K) | (69K) | (72.5K) | |
| Change To Netincome | 4.6M | (3.7M) | 16.3M | 17.0M | 19.5M | 20.5M | |
| Change To Liabilities | 14.0M | (5.1M) | 4.8M | (398K) | (358.2K) | (340.3K) | |
| Net Borrowings | (1.6M) | (2.9M) | (6.3M) | (2.7M) | (2.4M) | (2.3M) | |
| Issuance Of Capital Stock | 106.3M | 209K | 88.6M | 65.4M | 58.9M | 58.1M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.